See every side of every news story
Published loading...Updated

Fund Profiles' New Top Picks: Buy the Crashed Giant

Summary by Dagens Industri
Two new companies have taken their place in Carnegie's Strategy Fund – a pharmaceutical company facing headwinds and an engineering giant in transition. The managers' assessment: The market is turning a blind eye to short-term concerns and missing out on long-term value.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right

Two new companies have taken their place in Carnegie's Strategy Fund – a pharmaceutical company facing headwinds and an engineering giant in transition. The managers' assessment: The market is turning a blind eye to short-term concerns and missing out on long-term value.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Dagens industri broke the news in on Thursday, July 10, 2025.
Sources are mostly out of (0)